Indication
Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- PEDEA 5 mg/ml SOLUCION INYECTABLESpain · 5 mg · solución inyectable · Recordati Rare DiseasesSame brand
- PedeaCroatiaSame brand
- Pedea 5 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Orphan Europe SARLSame brand
- Pedea®Serbia · 5mg/mL · rastvor za injekciju · Clinres Farmacija D.O.O. Beograd · 2 entriesSame brand